A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- Bristol-Myers Squibb
- Study ID
- NCT05827016
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Iberdomide — DRUGSpecified dose on specified days
- Lenalidomide — DRUGSpecified dose on specified days
Study Details
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).
Key Dates
- First listed
- Apr 24, 2023
- Start date
- Jun 22, 2023
- Status verified
- Jun 2026
- Primary completion
- Mar 15, 2029
- Completion
- Jan 1, 2036
Study Design
- Enrollment
- 1,230 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Arm A1: Iberdomide Dose 1
- Experimental: Arm A2: Iberdomide Dose 2
- Experimental: Arm A3: Iberdomide Dose 3
- Active Comparator: Arm B: Lenalidomide
Primary Outcome Measure
Progression-free survival (PFS) [ Time Frame: Up to 6 years ]
Locations (44)
Find similar trials in Aurora, CO
By condition
By specialty
Related Studies
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Family Study of Lymphoproliferative DisordersRecruiting · Mayo Clinic · Rochester, Minnesota
- Collection of Samples and Clinical Data From Patients With Amyloid DiseasesRecruiting · Boston Medical Center · Boston, Massachusetts
- Collection of Tissue Samples for Cancer ResearchRecruiting · National Cancer Institute (NCI) · Atlanta, Georgia